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Abstract
We consider a polymerization (fragmentation) model with size-dependent parameters involved
in prion proliferation. Using power laws for the different rates of this model, we recover the shape
of the polymerization rate using experimental data. The technique used is inspired from [30], where
the fragmentation dependence on prion strains is investigated. Our improvement is to use power
laws for the rates, whereas [30] used a constant polymerization coefficient and linear fragmentation.
Keywords Aggregation-fragmentation equations, self-similarity, eigenproblem, size repartition, poly-
merization process, data fitting, inverse problem.
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1 Introduction
Polymerization of prion proteins is a central event in the mechanism of prion diseases. The cells
naturally produce the normal form of this protein (PrPc), but there exists a pathogenic form (PrPsc)
present in infected cells as polymers. These polymers have the ability to transconform and attach the
normal form by a polymerization process not yet very well understood. Mathematical modelling is a
promising tool to investigate this mechanism, provided we can find accurate parameters.
We consider the following model of prion proliferation (see [1, 2, 10, 12]):


dV (t)
dt
= λ− V (t)
[
δ +
∫ ∞
0
τ(x)u(x, t) dx
]
,
∂
∂t
u(x, t) = −V (t)
∂
∂x
(
τ(x)u(x, t)
)
− [µ0 + β(x)]u(x, t) + 2
∫ ∞
x
β(y)κ(x, y)u(y, t) dy,
u(0, t) = 0,
u(x, 0) = u0(x).
(1)
This equation is the continuous version of the discrete model of [17] (see [3] for the derivation).
System (1) is a quite general model able to reproduce biological experimental results (see [15]). In this
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equation, V (t) is the quantity of PrPc which is produced by the cell with a rate λ, and degraded with
the rate δ. The quantity of aggregates of PrPsc with size x at time t is denoted by u(x, t). Polymers
of PrPsc can attach monomers (PrPc) with rate τ and can split themselves in two smaller polymers
with rate β. To fit with experimental observations [29], the polymerization and fragmentation rates
should depend on the polymer size x (see [1, 2]). When fragmentation occurs, a polymer of size y
produces two pieces of size x and y − x with the probability κ(x, y). The natural assumptions (see
[20, 21, 24, 12]) on the kernel κ are then
Supp κ ⊆ {(x, y), 0 ≤ x ≤ y} (2)
since fragmentation produces smaller aggregates than the initial one,
∀y > 0,
∫
κ(x, y) dx = 1 (κ(·, y) is a probability measure) (3)
and
∀x ≤ y, κ(x, y) = κ(y − x, y) (4)
because of the indistinguishability of the two pieces of sizes x and y − x after fragmentation. A
consequence of the assumptions (2)-(4) is that the mean size of the fragments obtained from a polymer
of size y is y/2 :
∀y > 0,
∫
xκ(x, y) dx =
y
2
. (5)
In the discrete model of [16, 17, 18], a critical size n of polymers is considered. Under this size,
the polymers are unstable, so the proteins that compose them go back to their normal form PrPc.
This effect is taken into account in the continuous model of [10, 11] with the critical size x0. As
a consequence, there is one more integral term of apparition of monomers in the equation on V.
Nevertheless, even if n > 0 in the discrete model, the value of x0 can be taken equal to 0 in the
continuous one, as justified in [3]. Then the fact that small polymers are unstable, and so do not exist,
is taken into account by the boundary condition u(0, t) = 0. The parameter µ0 is a death term which
will be discussed later.
In the article [30], model (1) with the specific parameters of [6, 10, 11, 16, 17, 18] is used. It assumes
that the polymerization rate does not depend on polymer size (τ(x) ≡ τ0) and the fragmentation is
described by β(x) = β0x and κ(x, y) = 1l0≤x≤y
1
y
. In this case, equation (1) can be reduced to a non-
linear system of ODEs (see [6, 10, 11] or even [16, 17, 18]). This system is used in [30] to investigate the
parameters involved in the so-called “prion strain phenomenon”. This phenomenon is the ability of the
same encoded protein to encipher a multitude of phenotypic states. Prion strains are characterized by
their incubation period (time elapsed between experimental inoculation of the PrPsc infectious agent
and clinical onset of the disease) and their lesion profiles (patterns produced by the death of neurones)
in the brain [9]. A reason for the strain diversity can be that there exist various conformation states of
PrPsc, namely various misfoldings of the prion protein, which lead to various biological and biochemical
properties [22, 27]. These different conformations could be characterizable by their different stability
against denaturation. Indeed, recent studies on prion disease have confirmed that the incubation
time is related not only to the quantity of pathogenic protein inoculated (
∫
u0(x) dx) and the level of
expression of PrPc (λ), but also to the resistance of prion strains against denaturation [14] in terms
of the concentration of guanide hydrochloride (Gdn-HCl) required to denature 50% of the disease-
causing protein. Other studies have highlighted a strong relationship between the stability of the
prion protein against denaturation and neuropathological lesion profiles [13, 28]. A natural question is
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then to know how the conformation states of the PrPsc protein affect the parameters of model (1) and
more precisely which of these parameters is the most strain dependent. One of the conclusions of [30]
is that the key parameter describing strain-dependent replication kinetics is the fibril breakage rate β0.
Using the model, some coefficients already defined in [17] are calculated from experimental data, and
the dependence between them indicates that the fragmentation rate β0 is the most adapted parameter
to be strain dependent. But, in this framework, the fragmentation dependence is not sufficient to
fit the data precisely, and the polymerization rate τ0 is also assumed to change with the strain. In
particular, to keep a one-parameter family of models, the polymerization rate is assumed to depend
on the fragmentation one through a power relation:
∃φ s.t. τ0 = β0
φ. (6)
However, polymerization and fragmentation are two different biochemical processes which have no
reason to be linked together.
In this paper we prove that we can get rid of such a relation by considering a larger class of
parameters for model (1). We take advantage of a general framework developed in [1, 2, 12], where
coefficients can be more general than in [6, 10, 11, 16, 17, 18, 30], and we consider power laws as in
[7, 8, 12, 19]. Thanks to this extension, we find a shape for the polymerization rate allowing us to fit
experimental data with only the fragmentation rate dependent on strain. The experimental data we
use are the stability against denaturation G and the growth rate of the quantity of PrPsc (r), which
is linked to the incubation time. These data are strain dependent, and we can find in [30] estimated
empirical values for different strains. In Section 2, we present the class of coefficients we consider, and
give the necessary assumptions for the mathematical investigations. Most of these assumptions are
already made in [17, 30] and, thanks to them, we are able to link r and G to the mathematical model.
In Section 3 we give the dependence of these parameters on the polymerization and fragmentation
rates. Then we give a relation between them using only the fragmentation dependency on strain and
are able to fit data with an accurate shape of the polymerization rate.
2 Assumptions and Method
To avoid the use of a power relation like (6) between the polymerization and the fragmentation, we
allow the parameters τ and β to depend on the size x with power laws :
∃γ, ν and β0, τ0 s.t., ∀x > 0, β(x) = β0x
γ and τ(x) = τ0x
ν . (7)
Concerning the fragmentation kernel κ, we assume that there exists a measure κ0 on [0, 1] such that
∀x, y > 0, κ(x, y) =
1
y
κ0
(x
y
)
. (8)
Then the natural assumptions on κ become
∫ 1
0
κ0(z) dz = 1 and κ0(z) = κ0(1− z). (9)
We assume that the exponents ν, γ, the kernel κ0 and the death rate µ0 are strain independent unlike
the “intensities” β0 and τ0. First, we look which of β0 and τ0 is the most characteristic of the strain.
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Then we find a value of ν allowing to fit experimental data as well as [30] but without assumption (6).
We will see in Section 3 that the method naturally gives the parameter ν, because it turns out that γ
and κ0 do not appear in the final argument.
The method proposed in [17, 30] is to investigate the dynamics of the system (1) linearized at the
disease-free equilibrium. Then we can use the eigenelements as suggested in [1, 2]. To make this
approximation valid, we make some classical assumptions. First we assume that, in the biological
experiments (namely before animal death), the amount of PrPc in cells remains close to the sane
value V¯ = λ
δ
(obtained by setting u ≡ 0 in the first equation of (1)). Quantity V being assumed to be
constant, we consider the eigenelements r and U of the equation for polymers associated with V¯ :


rU(x) = −V¯
∂
∂x
(
τ(x)U(x)
)
− [µ0 + β(x)]U(x) + 2
∫ ∞
x
β(y)κ(x, y)U(y) dy,
U(0) = 0,
∫
U(x) dx = 1.
(10)
The principal eigenvalue r represents the growth rate of the solutions, and the eigenvector U is the
corresponding size distribution of polymers. To consider that the size distribution is close to this
profile along the experiments, we assume that the initial value u0(x) is already close to U . It is a
reasonable assumption if contaminations are made from other infected individuals. Then the solution
of (1) is reduced to
V (t) ≃ V¯ and u(x, t) ≃
[∫
u0(y)dy
]
U(x)ert. (11)
To solve our problem, we use the idea that the eigenelements r and U change with the prion strains
(see [2, 15] for instance). Because present experiments do not allow one to measure the size distribution
U , we link it to the stability against denaturation G by the relation
∃a > 0, b s.t. G = ax¯+ b (12)
where x¯ =
∫
xU(x) dx is the mean size of the polymers since
∫
U(x) dx = 1. Such an affine dependence,
suggested in [30], is based on the idea that the longer x¯ is, the larger G will be. In [13, 30] we can
find estimated empirical values of G (as a concentration, in mol, of Gnd-HCL required to denature
50% of PrPsc) and of the growth rate r (computed from measures of incubation times thanks to the
assumption of an exponential growth homogeneous in the brain). These values are reported in Table 1.
Prion strain 139A ME7 BSE Sc237 RML vCJD Chandler Scrapie 301 V
r(day−1) 0.05 0.024 0.015 0.11 0.18 0.07 0.17 0.07
G(M) 2 2.9 2.8 1.6 1.7 1.85 2.2 2.2
Table 1: Estimated empirical values of the growth rate and the stability against denaturation for different
prion strains (data from [14, 30]).
In the next section, we find a relation between r and U by investigating their dependence on
parameters. Then we show that this relation allows us to fit the data of Table 1 with an accurate
choice of the polymerization exponent ν.
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3 Results
Proving the existence of solutions to the eigenvalue problem (10) is not easy and the theory was
first developed in [25, 19]. In [5], we could treat singular polymerization and fragmentation rates as
investigated here. It is proved in [5, 19] that solutions exist under the condition
γ + 1− ν > 0. (13)
Moreover, following the idea of [8], we are able to give the dependence of r and U on the parameters
V, µ0, β0 and τ0 for given γ, ν and κ0 (unknown but strain independent). Define r1 and U1 by the
eigenequation given for β0 = V¯ τ0 = 1 and µ0 = 0 by
r1U1(x) = −
∂
∂x
(
xνU1(x)
)
− xγU1(x) + 2
∫ ∞
x
yγκ0
(x
y
)
U1(y)
dy
y
. (14)
Then r1 and U1 depend only on γ, ν and κ0, and we have the following lemma, which we use later on.
Lemma 1 The eigenelements r and U solution of (10) satisfy
r =
(
V τ0
) γ
1+γ−ν β0
1−ν
1+γ−ν r1 − µ0 and U(x) =
( β0
V τ0
) 1
1+γ−ν
U1
(( β0
V τ0
) 1
1+γ−ν x
)
. (15)
Proof. The proof is based on a homogeneity argument. First we write (10) as
r + µ0
V τ0
U(x) = −
∂
∂x
(
xνU(x)
)
−
β0
V τ0
xγU(x) + 2
β0
V τ0
∫ ∞
x
yγκ0
(x
y
)
U(y)
dy
y
(16)
and we set α = β0
V τ0
and R = r+µ0
V τ0
. The rescaled function v defined by U(x) = αkv(αkx) satisfies the
equation
αkRv(x) = −αk(2−ν)
∂
∂x
(
xνv(x)
)
− αk+1−kγxγv(x) + 2αk+1−kγ
∫ ∞
x
yγκ0
(x
y
)
v(y)
dy
y
. (17)
We choose k = 11+γ−ν (which is possible since (13) is satisfied) and obtain
α
ν−1
1+γ−νRv(x) = −
∂
∂x
(
xνv(x)
)
− xγv(x) + 2
∫ ∞
x
yγκ0
(x
y
)
v(y)
dy
y
. (18)
Comparing (14) and (18), the uniqueness of eigenelements ensures that
R = α
1−ν
1+γ−ν r1 and v(x) = U1(x) (19)
because
∫
v(x)dx =
∫
U(x)dx, and the lemma is proved.
We are now able to give the dependence of r and x¯ on the parameters β0, τ0 and µ0. The mean
length of the aggregates at time t is defined as the quotient
∫
xu(x, t) dx∫
u(x, t) dx
. So, using the approximation
(11), we obtain that this quantity is constant in time and equal to
x¯ =
∫
xU(x) dx. (20)
Then, thanks to Lemma 1, we conclude the following corollary.
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Corollary 1 Under assumptions (7)-(9) and (13), there are two constants r1 and x¯1 (depending only
on γ, ν and κ0) such that
r =
(
V τ0
) γ
1+γ−ν β0
1−ν
1+γ−ν r1 − µ0 and x¯ =
(V τ0
β0
) 1
1+γ−ν
x¯1. (21)
Proof. Using Lemma 1, we immediately have x¯ =
(V τ0
β0
) 1
1+γ−ν
x¯1 with x¯1 =
∫
xU1(x) dx.
We have obtained the dependence of r and x¯ on the a priori strain-dependent parameters β0 and
τ0. Using assumption (12), we deduce the dependence of the stability against denaturation G
G = a
(V τ0
β0
) 1
1+γ−ν
x¯1 + b. (22)
In [30], the exponent γ of the fragmentation rate is equal to 1. Here we do not impose any value
for γ but, nevertheless, we consider that it is positive. Indeed the larger the polymers are, the more
easily they break themselves. Consequently, a strain-dependency of τ0 cannot lead to a decreasing
correspondence between r and G, as observed in Figure 1, since we have assumed that γ + 1− ν and
a are positive. Thus it indicates that the key strain-dependent parameter should be β0. With this
assumption, we obtain an implicit expression of G as a function of r :
G = A(r + µ0)
1
ν−1 + b (23)
where A and b are constants (namely strain independent). This model is used to fit the data.
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Figure 1: Experimental values of G and r for different
strains are plotted (circles). Then these data are fitted
using the reduced model (23) with µ0 = 0 and µ0 free.
Ar
1
ν−1 +b A(r+µ0)
1
ν−1 +b
ν -0.482 0.316
µ0 0 0.023
A 0.083 0.01
b 1.54 1.69
R2 0.7 0.72
Table 2: Best-fitting parameters obtained with the
two different models. The correlation coefficient R2 is
also reported in the last row.
First we assume as in [30] that the death rate µ0 is equal to zero. Then we obtain a model already
considered by [30] (Table 3, page 5). In our framework, we can also let µ0 be free and fit the data with
the model (23). As we can see in Table 2, the accuracy of the fitting is a little bit better with this
6
generalization than in the case µ0 = 0. But the most significant difference between the two fittings is
the shape of τ : it is a decreasing function of x in the first case (ν < 0) and it is an increasing function
in the second case (ν > 0).
4 Conclusion and Perspectives
Thanks to a larger class of parameters than [30], we are able to fit experimental data by considering
only the fragmentation rate to be dependent on strains. We even obtain a more general model and
so a more accurate fitting. But, because the parameter profiles are not a priori known, we cannot
find x¯ from experimental data and have to postulate a particular dependence (12), whereas this was
a consequence of the model in [30]. To validate it, new data are necessary, for instance values of x¯
obtained by an experimental size distribution.
A consequence of the method is the prescription of the shape of the polymerization rate from
experimental data, and also the death rate µ0. Nevertheless, we notice a significant difference between
the two recovered exponents ν obtained by assuming that µ0 = 0 or not. In particular, one is negative
and the other one positive (see Table 2). The idea of comparing parameters from different strains
has been deeply exploited here. But the fact that there are only a few different strains in comparison
to the number of fitting parameters is a weakness for precise fitting and precise determination of τ.
Some parameters such as µ0 or b should be previously determined by another method and from other
data. Furthermore, the parameters of model (1) could have a size dependence more general than that
given by power laws. A complete inverse problem is to recover all the size-dependent parameters from
experimental data without the restriction to a class of shape. This problem is very complicated, even
though first elementary models are treated in [4, 26, 23]. Moreover, it requires more information such
as the size distribution U and not only the mean size x¯.
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